Former Leo Pharma EVP tapped to lead Oncopeptides through difficult times
The Swedish biotech company is facing rough regulatory headwinds, and has now tapped Leo Pharma’s former European region head for the CEO role.
by albert rønning-andersson, translated by daniel pedersen
As Oncopeptides navigates choppy regulatory waters in the US, the biotech company appoints a new person to steer the ship.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Janssen submits Genmab-developed drug for European approval
For subscribers
